Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NYSE - Nasdaq Real Time Price USD

Hims & Hers Health, Inc. (HIMS)

Compare
39.86
-11.45
(-22.32%)
At close: February 25 at 4:00:02 PM EST
41.54
+1.68
+(4.21%)
Pre-Market: 5:56:37 AM EST
Loading Chart for HIMS
DELL
  • Previous Close 51.31
  • Open 39.88
  • Bid 41.05 x 1300
  • Ask 40.15 x 900
  • Day's Range 36.02 - 43.22
  • 52 Week Range 11.20 - 72.98
  • Volume 77,381,305
  • Avg. Volume 16,812,168
  • Market Cap (intraday) 8.856B
  • Beta (5Y Monthly) 1.35
  • PE Ratio (TTM) 75.21
  • EPS (TTM) 0.53
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 42.45

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

www.forhims.com

1,637

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HIMS

View More

Related Videos: HIMS

Performance Overview: HIMS

Trailing total returns as of 2/25/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

HIMS
64.85%
S&P 500
1.25%

1-Year Return

HIMS
318.70%
S&P 500
17.03%

3-Year Return

HIMS
652.08%
S&P 500
35.82%

5-Year Return

HIMS
294.65%
S&P 500
90.37%

Compare To: HIMS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HIMS

View More

Valuation Measures

Annual
As of 2/25/2025
  • Market Cap

    8.86B

  • Enterprise Value

    8.57B

  • Trailing P/E

    75.21

  • Forward P/E

    80.65

  • PEG Ratio (5yr expected)

    4.52

  • Price/Sales (ttm)

    6.39

  • Price/Book (mrq)

    18.58

  • Enterprise Value/Revenue

    5.80

  • Enterprise Value/EBITDA

    108.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.54%

  • Return on Assets (ttm)

    7.18%

  • Return on Equity (ttm)

    30.71%

  • Revenue (ttm)

    1.48B

  • Net Income Avi to Common (ttm)

    126.04M

  • Diluted EPS (ttm)

    0.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    300.25M

  • Total Debt/Equity (mrq)

    2.38%

  • Levered Free Cash Flow (ttm)

    178.69M

Research Analysis: HIMS

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 481.14M
Earnings 26.02M

Q1'24

Q2'24

Q3'24

Q4'24

0
100M
200M
300M
400M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

19.75 Low
42.45 Average
39.86 Current
85.00 High
 

Company Insights: HIMS

Research Reports: HIMS

View More
  • Raising target price to $61.00

    HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $61.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Raising target price to $46.00

    HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $46.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Raising target price to $44.00

    HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $44.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Raising target price to $33.00

    HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

People Also Watch